Vaccine site-associated sarcoma and malignant lymphoma in cats: a report of six cases (1997-2002).
Six cats developed malignant lymphoma 3 to 45 months after treatment for vaccine site-associated sarcoma. During the same time period, 184 cats were evaluated in the teaching hospital for vaccine site-associated sarcomas. Feline vaccine site-associated sarcoma is not believed to be associated with feline leukemia virus (FeLV) infection. Five of six cats were negative by enzyme-linked immunosorbent assay for FeLV antigens at the times of diagnosis of both sarcoma and lymphoma, and no cats were infected with feline immunodeficiency virus.
Madewell
Bruce R
BR
Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, California 95616, USA.
Gieger
Tracy L
TL
Pesavento
Patricia A
PA
Kent
Michael S
MS
D000818:Animals; D002371:Cat Diseases / Q000209:etiology*; D002415:Cats; D005260:Female; D005256:Leukemia Virus, Feline / Q000276:immunology; D016582:Leukemia, Feline / Q000453:epidemiology; D008223:Lymphoma / Q000209:etiology / Q000662:veterinary*; D008297:Male; D012307:Risk Factors; D012509:Sarcoma / Q000209:etiology / Q000662:veterinary*; D012878:Skin Neoplasms / Q000209:etiology / Q000662:veterinary*; D014611:Vaccination / Q000009:adverse effects / Q000662:veterinary*